CEO of Michigan CDMO explains how he nabbed monkeypox vaccine contract
As US cases of the monkeypox outbreak have now risen above 14,000, the government is moving quickly to make more doses available, with the Jynneos vaccine looking to be deployed wider as Bavarian Nordic’s sites in Europe get the all-clear from the FDA.
Meanwhile, a Grand Rapids, Michigan-based CDMO landed a deal with Bavarian Nordic, to fill and finish the vaccine. Grand River Aseptic Manufacturing, a relatively new player in the CDMO world, only being around since 2010, announced it received the deal from Bavarian Nordic as well as approval from HHS and BARDA to increase the domestic supply of Jynneos.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.